pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,462 catalysts · 6,181 phase readout · 2,275 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,181
  • 8k filing2,275
  • earnings390
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT05636540: In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

Sponsor: Heather Wachtel. Phase: EARLY_PHASE1. Conditions: Pheochromocytoma, Paraganglioma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07720440: Nociception Level Index Monitoring During Cesarean Section

Sponsor: Istinye University. Phase: NA. Conditions: Cesarean Section, Postoperative Pain After Cesarean Section, Pain Management

full page →ctgov ↗
›COMPLETEDphase readoutNCT06454240: A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps

Sponsor: Sanofi. Phase: PHASE2. Conditions: Chronic Rhinosinusitis With Nasal Polyps

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07593040: Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma

Sponsor: Vall d'Hebron Institute of Oncology. Phase: PHASE2. Conditions: Renal Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05745389: CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Sponsor: CorEvitas. Phase: . Conditions: Alopecia Areata

full page →ctgov ↗
›COMPLETEDphase readoutNCT07723989: Gamified Program in Primary School Physical Education

Sponsor: University of Jaén. Phase: NA. Conditions: Physical Activity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07370389: The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster

Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00637689: Improving Outcomes Assessment in Chronic GVHD

Sponsor: Fred Hutchinson Cancer Center. Phase: . Conditions: Chronic Graft Versus Host Disease

full page →ctgov ↗
›TERMINATEDphase readoutNCT04095689: Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer

Sponsor: The Methodist Hospital Research Institute. Phase: PHASE2. Conditions: Triple Negative Breast Cancer, Anthracycline-refractory TNBC

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06280989: Effect of Kinesio Taping Versus Myofascial Release on Menstrual Low Back Pain

Sponsor: Cairo University. Phase: NA. Conditions: Low Back Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06000943: Ischemic And Bleeding Risk Assessment After TAVR

Sponsor: Niguarda Hospital. Phase: . Conditions: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement

full page →ctgov ↗
›COMPLETEDphase readoutNCT03709043: Addressing Heavy Alcohol Use Consumption With Kudzu

Sponsor: Glenn-Milo Santos. Phase: PHASE2. Conditions: Alcohol Use Disorder, Sexually Transmitted Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT05888415: WELL-being Improvement Following Sophrology Practice

Sponsor: University Hospital, Clermont-Ferrand. Phase: . Conditions: Well-being

full page →ctgov ↗
›TERMINATEDphase readoutNCT04504435: Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Leishmaniasis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06788925: Clinical Evaluation of Effectiveness of the "Therm'Up" Heating Device

Sponsor: ThermoTrauma. Phase: NA. Conditions: Hypothermia Due to Cold Environment

full page →ctgov ↗
›COMPLETEDphase readoutNCT06904976: Nature-based Contemplation and Spiritual Well-being Among Adults With Moderate Prolonged Grief Symptoms

Sponsor: University of Twente. Phase: NA. Conditions: Grief, Spiritual Wellbeing

full page →ctgov ↗
›RECRUITINGphase readoutNCT07378176: Prognosis of Primary Aldosteronism: A Prospective Cohort Study

Sponsor: Xinjiang Medical University. Phase: . Conditions: Primary Aldosteronism

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07205484: Long-Term Outcomes of Early Communication Intervention for Deaf/Hard of Hearing Toddlers

Sponsor: Northwestern University. Phase: PHASE2. Conditions: Hearing Loss, Bilateral

full page →ctgov ↗
›RECRUITINGphase readoutNCT06413433: Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

Sponsor: Axsome Therapeutics, Inc.. Phase: PHASE3. Conditions: Binge-Eating Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07472348: Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors

Sponsor: ASST Fatebenefratelli Sacco. Phase: . Conditions: Tuberculosis Infection, Tuberculosis Infection, Latent

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07720648: A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid Eye Disease

Sponsor: Beijing Kanghong Biological Medicine Co., Ltd.. Phase: PHASE3. Conditions: Thyroid Eye Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06425055: Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)

Sponsor: Enyo Pharma. Phase: PHASE2. Conditions: Alport Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07649655: EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer

Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Unresectable/Metastatic Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06549855: PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Sponsor: Peking University People's Hospital. Phase: NA. Conditions: Endometrial Cancer, Endometrioid Carcinoma, Mismatch Repair Deficiency

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03534726: Edema and Fibrosis CMR Imaging in Cardiomyopathy

Sponsor: University of Pennsylvania. Phase: . Conditions: Cardiomyopathies

full page →ctgov ↗
›COMPLETEDphase readoutNCT06778226: ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion

Sponsor: University of Miami. Phase: . Conditions: Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT06420726: Resistance Exercise and Creatine in Colorectal Cancer

Sponsor: University of South Carolina. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06514326: The Impact of Mechanisms of Action in Unguided Digital Mental Health Interventions

Sponsor: University of Haifa. Phase: NA. Conditions: DPT-STD, DPT-TP

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07641985: Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer Patients

Sponsor: Maastricht University Medical Center. Phase: NA. Conditions: Breast Cancer, Breast Reconstruction, Breast Reconstruction After Mastectomy, Breast Cancer Radiation, Lipofilling

full page →ctgov ↗
›RECRUITINGphase readoutNCT07738185: The Impact of Post-Frenotomy Massages on Ankyloglossia Recurrence and Feeding Outcomes

Sponsor: Isaac Elijah. Phase: NA. Conditions: Ankyloglossia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06715943: Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment

Sponsor: Chengdu Suncadia Medicine Co., Ltd.. Phase: PHASE3. Conditions: Paroxysmal Nocturnal Hemoglobinuria

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06113315: A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Sarcoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07718035: Evaluating the Effectiveness of the Moving to Emptiness Technique in Reducing Counsellors' Compassion Fatigue

Sponsor: University of Malaya. Phase: NA. Conditions: Compassion Fatigue

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07596108: Calibre vs. COSMED

Sponsor: Duke University. Phase: NA. Conditions: Cardiorespiratory Fitness

full page →ctgov ↗
›COMPLETEDphase readoutNCT04617925: A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

Sponsor: Stichting European Myeloma Network. Phase: PHASE2. Conditions: AL Amyloidosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07407725: Clinical Outcome Assessment for AT & BCI

Sponsor: Shirley Ryan AbilityLab. Phase: NA. Conditions: Spinal Cord Injury, ALS (Amyotrophic Lateral Sclerosis)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06845176: Combining Motor Imagery and Tendon Vibration on the Effectiveness of Motor Imagery

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Healthy Volunteer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06052176: Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center. Phase: PHASE2. Conditions: Cirrhosis, Hepatic Encephalopathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05005117: Laparoscopic Approach for Emergency Colon Resection

Sponsor: Joint Authority for Päijät-Häme Social and Health Care. Phase: NA. Conditions: Laparoscopic Surgery, Colorectal Cancer, Colorectal Disorders, Emergencies, Complication of Surgical Procedure, Long-term Effects of Cancer Treatment

full page →ctgov ↗
›RECRUITINGphase readoutNCT06909240: Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)

Sponsor: Hvidovre University Hospital. Phase: NA. Conditions: Deep Vein Thrombosis (DVT)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04670640: Mechanistic Interventions and Neuroscience of Dissociation

Sponsor: Emory University. Phase: NA. Conditions: Dissociation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07621289: Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe

Sponsor: University Hospital, Caen. Phase: . Conditions: Cancer, Anticancer Treatment, Cardiovascular Disease Risk Factor, Cardiovascular Diseases, Hematological Malignancies

full page →ctgov ↗
›RECRUITINGphase readoutNCT06239974: Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM)

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Chest Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07391774: Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07731997: IVUS Guidance in BTK Interventions

Sponsor: Shin Kong Wu Ho-Su Memorial Hospital. Phase: NA. Conditions: Chronic Limb-Threatening Ischemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07227597: A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Small Cell Lung Cancer Extensive Stage

full page →ctgov ↗
›TERMINATEDphase readoutNCT07668310: Effectiveness of PErcutaneous Ultrasound-guided Carpal Tunnel Release: a Non-inferiority Study With Surgery as Comparator

Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche. Phase: NA. Conditions: Carpal Tunnel Syndrome (CTS)

full page →ctgov ↗
›WITHDRAWNphase readoutNCT07413510: Precision Nursing vs Conventional Care in Laparoscopic Colorectal Cancer Surgery: A Randomized Controlled Trial

Sponsor: Jiangsu Cancer Institute & Hospital. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07381010: Learn About Caring for a Person Living With Dementia

Sponsor: Texas Christian University. Phase: PHASE1. Conditions: Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06890013: A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices

Sponsor: Aristotle University Of Thessaloniki. Phase: . Conditions: Acute Coronary Syndromes, Flow Mediated Dilation, Endothelial Function (FMD)

full page →ctgov ↗
← prev
page 168 of 170
next →